Background: It has long been known that the prevalence and mortality rates of coronary artery disease have increased in the recent decade.
The purpose of this study is to compare the effect of atorvastatin on flow-mediated dilatation (FMD), total cholesterol (TC), and low-density lipoproteins (LDL) in patients with dyslipidemia who are not treated with any hypolipemiant medication (DYS-STAT) versus dyslipidemia patients who are treated with atorvastatin (DYS+STAT).
The DYS-STAT group had a higher prevalence of elevated LDL and TC levels than the DYS+STAT group. In addition, the DYS-STAT group had lower FMD values than the DYS+STAT group.
Conclusion: Our findings imply that atorvastatin treatment improves endothelial function in dyslipidemia patients.Author(S) Details
Uchejeso Obeta
Department of Medical Laboratory Management, Federal School of Medical Laboratory Science, Jos, Nigeria.
Gumta Matthew
Department of Family Medicine, Our Lady of Apostle Hospital, Jos-Nigeria.
Obiora Ejinaka
Department of Medical Parasitology, Federal School of Medical Laboratory Science, Jos, Nigeria.
Adaeze Oreh
Department of Hospital Services, Federal Ministry of Health, Abuja, Nigeria
Nkereuwem Etukudoh
Department of Medical Laboratory Management, Federal School of Medical Laboratory Science, Jos, Nigeria.
Jonathan Sabulu
Federal Teaching Hospital, Gombe, Gombe State, Nigeria.
Jonathan Sabulu
Federal Teaching Hospital, Gombe, Gombe State, Nigeria.
View Book:- https://stm.bookpi.org/ETDHR-V1/article/view/5204
No comments:
Post a Comment